Back to search
FDAFDA · Food and drugs·Recall number D-0457-2023

Purely Soothing MSM Nasal Spray, 15%, packaged in 30ml, 1.014 fl. oz bottles, Manufactured by: Pharmedica USA, Phoenix, AZ, UPC 7 31034 91380 5

Published March 15, 2023 · Recall initiated: February 14, 2023

Summary

FDA records drug Class II recall D-0457-2023, published March 15, 2023 and initiated February 14, 2023. Recalling firm: Pharmedica USA, LLC; Status: Ongoing; Reported quantity: 995 bottles; Lot: Lot #: 1808051, Exp.: 01/01/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmedica USA, LLC
Distributor
Nationwide in the USA and Worldwide through e-commerce and trade shows
Lot
Lot #: 1808051, Exp.: 01/01/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Purely Soothing MSM Nasal Spray, 15%, packaged in 30ml, 1.014 fl. oz bottles, Manufactured by: Pharmedica USA, Phoenix, AZ, UPC 7 31034 91380 5 recalled?

Yes. FDA published recall D-0457-2023 on March 15, 2023. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail